Literature DB >> 19492321

Complementary and alternative medical therapies used by children with cancer treated at an Italian pediatric oncology unit.

Carlo Alfredo Clerici1, Laura Veneroni, Barbara Giacon, Luigi Mariani, Franca Fossati-Bellani.   

Abstract

BACKGROUND: Research has identified a growing use of complementary and alternative medicines (CAM) in the pediatric oncology setting and health care professionals should consider how they might interact with and/or be used in lieu of conventional treatment. The present study was designed to establish the prevalence of CAM usage at an Italian pediatric oncology department, and the reasons why patients used these unconventional therapies. PROCEDURE: This was an observational study involving parents whose children were treated for tumors at the pediatric oncology unit of the Istituto Nazionale Tumori in Milano. Data were collected on their sociodemographic variables and their use of CAM by means of a self-administered questionnaire.
RESULTS: We distributed 145 questionnaires and 97 of them (67%) were returned. Judging from this survey, 12.4% of the children used at least one type of CAM and homoeopathy was the most often used. Benefits were reported by 83% of parents. The most common reasons for using CAM were to reduce the side-effects of conventional therapies. The oncologists taking care of the patients were notified of the child's use of CAM in only one case.
CONCLUSION: CAM were used not as a substitute but in addition to conventional treatments. In almost all cases, oncologists were not informed that a child was using CAM, posing a risk of any interaction with pharmacological treatments being inadequately understood.

Entities:  

Mesh:

Year:  2009        PMID: 19492321     DOI: 10.1002/pbc.22093

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  In vitro screening of tumoricidal properties of international medicinal herbs: part II.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Phytother Res       Date:  2010-12       Impact factor: 5.878

2.  A Feasibility Pilot Trial of Individualized Homeopathic Treatment of Fatigue in Children Receiving Chemotherapy.

Authors:  David Brulé; Biljana Gillmeister; Michelle Lee; Sarah Alexander; Adam Gassas; Eleanor Hendershot; Sue Zupanec; Lee Dupuis; Lillian Sung
Journal:  Integr Cancer Ther       Date:  2015-11-15       Impact factor: 3.279

3.  Use of complementary and alternative medicine by pediatric oncology patients during palliative care.

Authors:  Tim Schütze; Alfred Längler; Tycho Jan Zuzak; Pia Schmidt; Boris Zernikow
Journal:  Support Care Cancer       Date:  2016-02-02       Impact factor: 3.603

Review 4.  Effectiveness of integrative modalities for pain and anxiety in children and adolescents with cancer: a systematic review.

Authors:  Susan Thrane
Journal:  J Pediatr Oncol Nurs       Date:  2013 Nov-Dec       Impact factor: 1.636

5.  Use of Complementary and Alternative Medicine in Children with Cancer: A Study at a Swiss University Hospital.

Authors:  Tatjana Magi; Claudia E Kuehni; Loredana Torchetti; Laura Wengenroth; Sonja Lüer; Martin Frei-Erb
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

Review 6.  Add-On Complementary Medicine in Cancer Care: Evidence in Literature and Experiences of Integration.

Authors:  Elio Rossi; Mariella Di Stefano; Fabio Firenzuoli; Maria Valeria Monechi; Sonia Baccetti
Journal:  Medicines (Basel)       Date:  2017-01-24

7.  Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment.

Authors:  Emmanuelle Lüthi; Manuel Diezi; Nadia Danon; Julie Dubois; Jérôme Pasquier; Bernard Burnand; Pierre-Yves Rodondi
Journal:  BMC Complement Med Ther       Date:  2021-03-18

Review 8.  Global Use of Traditional and Complementary Medicine in Childhood Cancer: A Systematic Review.

Authors:  Caroline Diorio; Catherine G Lam; Elena J Ladas; Festus Njuguna; Glenn M Afungchwi; Katherine Taromina; Stacey Marjerrison
Journal:  J Glob Oncol       Date:  2016-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.